T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
84 hedge funds and large institutions have $66.2M invested in T2 Biosystems, Inc in 2018 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 26 increasing their positions, 17 reducing their positions, and 12 closing their positions.
53% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 17
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 12
1% less funds holding
Funds holding: 85 → 84 (-1)
33% less call options, than puts
Call options by funds: $204K | Put options by funds: $305K
63% less capital invested
Capital invested by funds: $181M → $66.2M (-$115M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.79M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$940K |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$587K |
| 4 |
BlackRock
New York
|
+$564K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$446K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$4.12M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.85M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.64M |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$1.55M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$1.17M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ARTA
101
A.R.T. Advisors
New York
| – | -$319K | -9 | Closed |
|
|
GCP
102
GSA Capital Partners
London,
United Kingdom
| – | -$242K | -7 | Closed |
|
103
Two Sigma Advisers
New York
| – | -$244K | -7 | Closed |
|
|
TI
104
Trexquant Investment
Stamford,
Connecticut
| – | -$216K | -6 | Closed |
|
|
DTL
105
Dynamic Technology Lab
Singapore
| – | -$188K | -5 | Closed |
|
|
JT
106
Jump Trading
Chicago,
Illinois
| – | -$144K | -4 | Closed |
|
|
BCM
107
Bayesian Capital Management
Brooklyn,
New York
| – | -$86K | -2 | Closed |
|
108
Fidelity Investments
Boston,
Massachusetts
| – | -$15K | – | – |
|
|
FIA
109
FNY Investment Advisers
New York
| – | -$2K | – | – |
|
TTOO Hedge Fund Activity: Q4 2018 in Review
84 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q4 2018, worth a combined $66.2M — down 63% from $181M a quarter earlier.
Fund positioning in TTOO was balanced in Q4 2018: 12 funds opened new positions, 12 closed out, 26 added to existing stakes and 17 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $1.79M. The largest seller was Millennium Management, exiting entirely with an estimated $4.12M sold.
- 84 institutional investors held T2 Biosystems, Inc (TTOO) as of Q4 2018, down from 85 in Q3 2018.
- Funds reported $66.2M of T2 Biosystems, Inc stock for Q4 2018, down 63% quarter-over-quarter.
- 12 funds opened new T2 Biosystems, Inc positions in Q4 2018 and 12 closed out, a net change of 0 holders.
- The largest T2 Biosystems, Inc buyer in Q4 2018 was Morgan Stanley, an estimated $1.79M added.
- The largest T2 Biosystems, Inc seller in Q4 2018 was Millennium Management, an estimated $4.12M sold.
Based on aggregated 13F filings for Q4 2018.